Literature DB >> 24676544

Lysophosphatidic acid receptor-5 negatively regulates cell motile and invasive activities of human sarcoma cell lines.

Yan Dong1, Miku Hirane, Mutsumi Araki, Nobuyuki Fukushima, Kanya Honoki, Toshifumi Tsujiuchi.   

Abstract

LPA signaling via LPA receptors [LPA receptor-1 (LPA1)-LPA6] mediates the several cellular responses in cancer cells, including cell motility and invasion. In the present study, to investigate a role of LPA5 in the cell motile and invasive activities of sarcoma cells, LPAR5 knockdown (HOSL5 and HT1080L5) cells were generated from human osteosarcoma HOS and fibrosarcoma HT1080 cells, respectively. In cell motility assays with cell culture inserts, HOSL5 and HT1080L5 cells indicated the high cell motile activities, compared with control cells. The cell invasive activities of HOSL5 and HT1080L5 cells were significantly higher than those of control cells. Moreover, the activities of matrix metalloproteinase (MMP)-2 and MMP-9 were measured by gelatin zymography. MMP-2 was significantly activated in HOSL5 cells, but not MMP-9. The elevated activities of MMP-2 and MMP-9 were found in HT1080L5 cells, in comparison with control cells. These results suggest that LPA signaling via LPA5 negatively regulates the cell motile and invasive activities of human sarcoma cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24676544     DOI: 10.1007/s11010-014-2042-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  24 in total

1.  Lysophosphatidic acid receptor-3 increases tumorigenicity and aggressiveness of rat hepatoma RH7777 cells.

Authors:  Kyoko Okabe; Mai Hayashi; Kohei Kato; Mai Okumura; Rie Fukui; Kanya Honoki; Nobuyuki Fukushima; Toshifumi Tsujiuchi
Journal:  Mol Carcinog       Date:  2011-12-07       Impact factor: 4.784

2.  Differential expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in human colon cancer cells.

Authors:  Megumu Tsujino; Minako Fujii; Kyoko Okabe; Toshio Mori; Nobuyuki Fukushima; Toshifumi Tsujiuchi
Journal:  Virchows Arch       Date:  2010-10-03       Impact factor: 4.064

3.  GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5.

Authors:  Chang-Wook Lee; Richard Rivera; Shannon Gardell; Adrienne E Dubin; Jerold Chun
Journal:  J Biol Chem       Date:  2006-06-14       Impact factor: 5.157

Review 4.  Matrix metalloproteinases: regulators of the tumor microenvironment.

Authors:  Kai Kessenbrock; Vicki Plaks; Zena Werb
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

5.  Homo- and hetero-dimerization of LPA/S1P receptors, OGR1 and GPR4.

Authors:  Alexander Zaslavsky; Lisam Shanjukumar Singh; Haiyan Tan; Huawen Ding; Zicai Liang; Yan Xu
Journal:  Biochim Biophys Acta       Date:  2006-08-30

6.  Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cells.

Authors:  Kohei Kato; Kyohei Yoshikawa; Eriko Tanabe; Misaho Kitayoshi; Rie Fukui; Nobuyuki Fukushima; Toshifumi Tsujiuchi
Journal:  Tumour Biol       Date:  2012-06-08

Review 7.  Diverse effects of LPA receptors on cell motile activities of cancer cells.

Authors:  Toshifumi Tsujiuchi; Miku Hirane; Yan Dong; Nobuyuki Fukushima
Journal:  J Recept Signal Transduct Res       Date:  2014-01-24       Impact factor: 2.092

8.  A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation.

Authors:  Shinya Shano; Kazuki Hatanaka; Shinsuke Ninose; Ryutaro Moriyama; Toshifumi Tsujiuchi; Nobuyuki Fukushima
Journal:  Biochim Biophys Acta       Date:  2007-12-05

Review 9.  Lysophosphatidic acid (LPA) and its receptors.

Authors:  Kyoko Noguchi; Deron Herr; Tetsuji Mutoh; Jerold Chun
Journal:  Curr Opin Pharmacol       Date:  2008-12-30       Impact factor: 5.547

10.  Mutations of lysophosphatidic acid receptor-1 gene during progression of lung tumors in rats.

Authors:  Takanori Yamada; Yumi Obo; Mami Furukawa; Mayuko Hotta; Ayako Yamasaki; Kanya Honoki; Nobuyuki Fukushima; Toshifumi Tsujiuchi
Journal:  Biochem Biophys Res Commun       Date:  2008-11-21       Impact factor: 3.575

View more
  4 in total

1.  LPAR5 confers radioresistance to cancer cells associated with EMT activation via the ERK/Snail pathway.

Authors:  Xiao-Ya Sun; Hao-Zheng Li; Da-Fei Xie; Shan-Shan Gao; Xin Huang; Hua Guan; Chen-Jun Bai; Ping-Kun Zhou
Journal:  J Transl Med       Date:  2022-10-05       Impact factor: 8.440

2.  Bioinformatic analysis and identification of potential prognostic microRNAs and mRNAs in thyroid cancer.

Authors:  Jianing Tang; Deguang Kong; Qiuxia Cui; Kun Wang; Dan Zhang; Qianqian Yuan; Xing Liao; Yan Gong; Gaosong Wu
Journal:  PeerJ       Date:  2018-05-04       Impact factor: 2.984

3.  Genetic expression profile-based screening of genes and pathways associated with papillary thyroid carcinoma.

Authors:  Shubin Li; Yihang Yin; Hong Yu
Journal:  Oncol Lett       Date:  2018-08-21       Impact factor: 2.967

4.  Lysophosphatidic Acid Receptor 5 (LPAR5) Plays a Significance Role in Papillary Thyroid Cancer via Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (mTOR) Pathway.

Authors:  Cheng-Yong Wu; Chen Zheng; Er-Jie Xia; Rui-Da Quan; Jing Hu; Xiao-Hua Zhang; Ru-Tian Hao
Journal:  Med Sci Monit       Date:  2020-01-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.